185
Views
2
CrossRef citations to date
0
Altmetric
Case Reports

A de novo mutation in PITX2 underlies a unique form of Axenfeld-Rieger syndrome with corneal neovascularization and extensive proliferative vitreoretinopathy

, , , , , & show all
Pages 358-362 | Received 19 Mar 2020, Accepted 09 May 2020, Published online: 19 May 2020

References

  • Alward WL. Axenfeld-Rieger syndrome in the age of molecular genetics. Am J Ophthalmol. 2000; 130(1):107–15. doi:10.1016/S0002-9394(00)00525-0. Cited in PubMed; PMID:11004268.
  • Shields MB, Buckley E, Klintworth GK, Thresher R. Axenfeld-Rieger syndrome. A spectrum of developmental disorders. Surv Ophthalmol. 1985; 29(6):387–409. doi:10.1016/0039-6257(85)90205-X. Cited in PubMed; PMID:3892740.
  • Hjalt TA, Semina EV. Current molecular understanding of Axenfeld-Rieger syndrome. Expert Rev Mol Med. 2005;7(25):1–17. doi:10.1017/S1462399405010082. Cited in PubMed; PMID:16274491.
  • Lines MA, Kozlowski K, Walter MA. Molecular genetics of Axenfeld-Rieger malformations. Hum Mol Genet. 2002; 11(10):1177–84. doi:10.1093/hmg/11.10.1177. Cited in PubMed; PMID: 12015277.
  • Kozlowski K, Walter MA. Variation in residual PITX2 activity underlies the phenotypic spectrum of anterior segment developmental disorders. Hum Mol Genet. 2000; 9(14):2131–39. doi:10.1093/hmg/9.14.2131. Cited in PubMed; PMID:10958652.
  • Quentien MH, Vieira V, Menasche M, Dufier JL, Herman JP, Enjalbert A, Abitbol M, Brue T. Truncation of PITX2 differentially affects its activity on physiological targets. J Mol Endocrinol. 2010;46(1):9–19. doi:10.1677/JME-10-0063. Cited in PubMed; PMID:20978111.
  • Reis LM, Tyler RC, Volkmann Kloss BA, Schilter KF, Levin AV, Lowry RB, Zwijnenburg PJ, Stroh E, Broeckel U, Murray JC, et al. PITX2 and FOXC1 spectrum of mutations in ocular syndrome. Eur J Hum Genet. 2012;20(12):1224–33. doi:10.1038/ejhg.2012.80. Cited in PubMed; PMID:22569110.
  • Perveen R, Lloyd IC, Clayton-Smith J, Churchill A, van Heyningen V, Hanson I, Taylor D, McKeown C, Super M, Kerr B, et al. Phenotypic variability and asymmetry of Rieger syndrome associated with PITX2 mutations. Invest Ophthalmol Vis Sci. 2000;41(9):2456–60. Cited in PubMed; PMID:10937553.
  • Amendt BA, Sutherland LB, Russo AF. Multifunctional role of the Pitx2 homeodomain protein C-terminal tail. Mol Cell Biol. 1999; 19(10):7001–10. doi:10.1128/MCB.19.10.7001. Cited in PubMed; PMID:10490637.
  • Footz T, Idrees F, Acharya M, Kozlowski K, Walter MA. Analysis of mutations of the PITX2 transcription factor found in patients with Axenfeld-Rieger syndrome. Invest Ophthalmol Vis Sci. 2009;50(6):2599–606. doi:10.1167/iovs.08-3251. Cited in PubMed; PMID:19218601.
  • D’haene B, Meire F, Claerhout I, Kroes HY, Plomp A, Arens YH, de Ravel T, Casteels I, De Jaegere S, Hooghe S, et al. Expanding the spectrum of FOXC1 and PITX2 mutations and copy number changes in patients with anterior segment malformations. Invest Ophthalmol Vis Sci. 2011;52(1):324–33. doi:10.1167/iovs.10-5309. Cited in PubMed; PMID:20881294.
  • Chrystal PW, Walter MA. Aniridia and Axenfeld-Rieger syndrome: clinical presentations, molecular genetics and current/emerging therapies. Exp Eye Res. 2019;189:107815. doi:10.1016/j.exer.2019.107815. Cited in PubMed; PMID: 31560925.
  • Gage PJ, Camper SA. Pituitary homeobox 2, a novel member of the bicoid-related family of homeobox genes, is a potential regulator of anterior structure formation. Hum Mol Genet. 1997; 6(3):457–64. doi:10.1093/hmg/6.3.457. Cited in PubMed; PMID:9147650.
  • Semina EV, Reiter R, Leysens NJ, Alward WL, Small KW, Datson NA, Siegel-Bartelt J, Bierke-Nelson D, Bitoun P, Zabel BU, et al. Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nat Genet. 1996;14(4):392–99. doi:10.1038/ng1296-392. Cited in PubMed; PMID:8944018.
  • Vieira V, David G, Roche O, de la Houssaye G, Boutboul S, Arbogast L, Kobetz A, Orssaud C, Camand O, Schorderet DF, et al. Identification of four new PITX2 gene mutations in patients with Axenfeld-Rieger syndrome. Mol Vis. 2006;12:1448–60. Cited in PubMed; PMID:17167399.
  • Borges AS, Susanna R Jr, Carani JC, Betinjane AJ, Alward WL, Stone EM, Sheffield VC, Nishimura DY. Genetic analysis of PITX2 and FOXC1 in Rieger syndrome patients from Brazil. J Glaucoma. 2002;11(1):51–56. doi:10.1097/00061198-200202000-00010. Cited in PubMed; PMID:11821690.
  • Brooks BP, Moroi SE, Downs CA, Wiltse S, Othman MI, Semina EV, Richards JE. A novel mutation in the PITX2 gene in a family with Axenfeld-Rieger syndrome. Ophthalmic Genet. 2004;25(1):57–62. doi:10.1076/opge.25.1.57.29002. Cited in PubMed; PMID:15255117.
  • Seifi M, Walter MA. Axenfeld-Rieger syndrome. Clin Genet. 2018;93(6):1123–30. doi:10.1111/cge.13148. Cited in PubMed; PMID:28972279.
  • Chen L, Martino V, Dombkowski A, Williams T, West-Mays J, Gage PJ. AP-2β is a downstream effector of PITX2 required to specify endothelium and establish angiogenic privilege during corneal development. Invest Ophthalmol Vis Sci. 2016;57(3):1072–81. doi:10.1167/iovs.15-18103. Cited in PubMed; PMID:26968737.
  • Gage PJ, Kuang C, Zacharias AL. The homeodomain transcription factor PITX2 is required for specifying correct cell fates and establishing angiogenic privilege in the developing cornea. Dev Dyn. 2014;243(11):1391–400. doi:10.1002/dvdy.24165. Cited in PubMed; PMID:25044936.
  • Gage PJ, Qian M, Wu D, Rosenberg KI. The canonical Wnt signaling antagonist DKK2 is an essential effector of PITX2 function during normal eye development. Dev Biol. 2008;317(1):310–24. doi:10.1016/j.ydbio.2008.02.030. Cited in PubMed; PMID:18367164.
  • Hendee KE, Sorokina EA, Muheisen SS, Reis LM, Tyler RC, Markovic V, Cuturilo G, Link BA, Semina EV. PITX2 deficiency and associated human disease: insights from the zebrafish model. Hum Mol Genet. 2018;27(10):1675–95. doi:10.1093/hmg/ddy074. Cited in PubMed; PMID:29506241.
  • Doward W, Perveen R, Lloyd IC, Ridgway AE, Wilson L, Black GC. A mutation in the RIEG1 gene associated with Peters’ anomaly. J Med Genet. 1999; 36(2):152–55. Cited in PubMed; PMID:10051017.
  • Weh E, Reis LM, Happ HC, Levin AV, Wheeler PG, David KL, Carney E, Angle B, Hauser N, Semina EV. Whole exome sequence analysis of Peters anomaly. Hum Genet. 2014;133(12):1497–511. doi:10.1007/s00439-014-1481-x. Cited in PubMed; PMID:25182519.
  • Xu Q, Wang Y, Dabdoub A, Smallwood PM, Williams J, Woods C, Kelley MW, Jiang L, Tasman W, Zhang K, et al. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell. 2004;116(6):883–95. doi:10.1016/S0092-8674(04)00216-8. Cited in PubMed; PMID:15035989.
  • Liu Y, Semina EV. Pitx2 deficiency results in abnormal ocular and craniofacial development in zebrafish. PLoS One. 2012;7(1):e30896. doi:10.1371/journal.pone.0030896. Cited in PubMed; PMID:22303467.
  • Arikawa A, Yoshida S, Yoshikawa H, Ishikawa K, Yamaji Y, Arita RI, Ueno A, Ishibashi T. Case of novel PITX2 gene mutation associated with Peters’ anomaly and persistent hyperplastic primary vitreous. Eye (Lond). 2010;24(2):391–93. doi:10.1038/eye.2009.114. Cited in PubMed; PMID:19461663.
  • Williams AL, Bohnsack BL. Neural crest derivatives in ocular development: discerning the eye of the storm. Birth Defects Res C Embryo Today. 2015;105(2):87–95. doi:10.1002/bdrc.21095. Cited in PubMed; PMID:26043871.
  • Lu M, Pressman C, Dyer R, Johnson RL, Martin JF. Function of Rieger syndrome gene in left-right asymmetry and craniofacial development. Nature. 1999;401(6750):276–78. doi:10.1038/45797. Cited in PubMed; PMID: 10499585.
  • Evans AL, Gage PJ. Expression of the homeobox gene Pitx2 in neural crest is required for optic stalk and ocular anterior segment development. Hum Mol Genet. 2005;14(22):3347–59. doi:10.1093/hmg/ddi365. Cited in PubMed; PMID: 16203745.
  • Kelberman D, Islam L, Holder SE, Jacques TS, Calvas P, Hennekam RC, Nischal KK, Sowden JC. Digenic inheritance of mutations in FOXC1 and PITX2: correlating transcription factor function and Axenfeld-Rieger disease severity. Hum Mutat. 2011;32(10):1144–52. doi:10.1002/humu.21550. Cited in PubMed; PMID:21837767.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.